The novel use of combined IL-1 and IL-6 inhibition in a patient with severe, aggressive, erosive, systemic-onset juvenile idiopathic arthritis
(Eur J Rheumatol 2017; 4: 68-69) DOI: 10.5152/eurjrheum.2016.055
(Eur J Rheumatol 2017; 4: 68-69) DOI: 10.5152/eurjrheum.2016.055
Derya Yıldırım, Rıza Can Kardaş, Burcugul Özkızıltaş, İbrahim Vasi, Hamit Küçük, Mehmet Akif Öztürk, Abdurrahman Tufan
(Eur J Rheumatol 2023; 10: 29-33) DOI: 10.5152/EuJRheum.2022.21180